Literature DB >> 26999624

A study of mild cognitive impairment in veterans: role of hypertension and other confounding factors.

Jie Bai1, Peng Wei2, Ning Zhao1, Ying Xiao1, Chunhui Yang3, Jun Zhong4, Yong Cai5, Yongchao Li6, Qin Zhu7, Xian Cao8, Li Sun9, Bing Wang10, Keqin Teng11, Shifeng Ling12, Hailai Ni1, Minghui Xie13, Jiping Tan14, Luning Wang14, Xiao-Mao Sun15, Wenjun Zhang1.   

Abstract

INTRODUCTION: Hypertension has shown to be an important risk factor for the decline in cognitive function. Aim of our study is to investigate the presence of cognitive impairment of the elders with hypertension and other confounding factors.
METHODS: This study was conducted on 400 veterans who were matched one-to-one with the confounding factors for assessing the presence of mild cognitive impairment using both MMSE and Montreal Cognitive Assessment (MoCA). The 13 related factors of patient data were studied.
RESULTS: The prevalence rate of cognitive impairment was 29.25%. Age (OR 2.679, 95%CI 1.663-6.875), sleep impairment (OR 1.117, 95%CI 1.754-7.422), uncontrolled hypertension (OR 1.522, 95%CI 1.968-4.454), type 2 diabetes (OR 2.464, 95%CI 1.232-4.931), and hyperlipidaemia (OR 1.411, 95%CI 1.221-8.988) are the risk factors for the cognitive deterioration, while the protective factors are high level of education (OR 0.032, 95%CI 0.007-0.149) and regular exercise (OR 0.307, 95%CI 0.115-0.818). DISCUSSION: Because some vascular disease risk factors, such as hypertension, can be treated effectively, cognitive decline related to these risk factors, and vascular disease per se, may be prevented or its course modified through more aggressive treatment and improved compliance.

Entities:  

Keywords:  Cognitive function; aging; diabetes; hypertension; vascular risk factors

Mesh:

Year:  2016        PMID: 26999624     DOI: 10.1080/13825585.2016.1161000

Source DB:  PubMed          Journal:  Neuropsychol Dev Cogn B Aging Neuropsychol Cogn        ISSN: 1382-5585


  5 in total

1.  Type 2 Diabetes Mellitus Is Associated with the Risk of Cognitive Impairment: a Meta-Analysis.

Authors:  Xiaojun Zhang; Xiaolu Jiang; Sufang Han; Qianqi Liu; Jing Zhou
Journal:  J Mol Neurosci       Date:  2019-04-04       Impact factor: 3.444

2.  Association of body mass index with amnestic and non-amnestic mild cognitive impairment risk in elderly.

Authors:  Feng Wang; Minghui Zhao; Zhaoli Han; Dai Li; Shishuang Zhang; Yongqiang Zhang; Xiaodong Kong; Ning Sun; Qiang Zhang; Ping Lei
Journal:  BMC Psychiatry       Date:  2017-09-15       Impact factor: 3.630

3.  Development of a Vietnamese version of the Revised Hasegawa's Dementia scale.

Authors:  Thi Phuong Tran; Duy Cuong Nguyen; Thi Van Quy Dang; Thi Khuyen Tran; Phong Tuc Vu; Minh Hoang Vu; Thu Hang Le; Thu Nandar Saw; Su Myat Cho; Tetsuyoshi Kariya; Eiko Yamamoto; Nobuyuki Hamajima; Yu Mon Saw
Journal:  Nagoya J Med Sci       Date:  2022-05       Impact factor: 0.794

Review 4.  Prevalence of mild cognitive impairment in patients with hypertension: a systematic review and meta-analysis.

Authors:  Jiawei Qin; Zexiang He; Lijian Wu; Wanting Wang; Qiuxiang Lin; Yiheng Lin; Liling Zheng
Journal:  Hypertens Res       Date:  2021-07-20       Impact factor: 3.872

5.  Prevalence of and Risk Factors for Cognitive Impairment Among Elderly Without Cardio- and Cerebrovascular Diseases: A Population-Based Study in Rural China.

Authors:  Li Ren; Lingling Bai; Yanan Wu; Jingxian Ni; Min Shi; Hongyan Lu; Jun Tu; Xianjia Ning; Ping Lei; Jinghua Wang
Journal:  Front Aging Neurosci       Date:  2018-03-28       Impact factor: 5.750

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.